GHRS(GHRS)
GHRS
ANALYST COVERAGE9 analysts
BUY
▲ +76.3%upside to target
L $32.00
Med $39.00consensus
H $65.00PRICE
Prev Close
21.77
Open
21.81
Day Range21.81 – 23.70
21.81
23.70
52W Range10.96 – 24.66
10.96
24.66
81% of range
VOLUME & SIZE
Avg Volume
229.1K
FUNDAMENTALS
P/E Ratio
-24.3x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
1.23
Market-like
TECHNICAL
RSI (14)
75
Overbought
Upcoming Events
EEarnings Report
Tomorrow
May 24
DEx-Dividend
In 90 days
Aug 21
PDividend Pay
In 128 days
Sep 28
GHRS News
About
gh research is a privately-held clinical-stage biopharmaceutical company developing novel therapies for the management of mental illness.
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Theis Terwey
Country
Ireland
Velichka ValchevaChief Executive Officer
Aaron CameronChief Operating Officer
Florian SchonhartingCo-Founder & Non-Executive Chairman of the Board
Magnus HalleCo-Founder & MD of Ireland
Julie RyanVice President of Finance